Delivery Order SPE2DB20D2014-SPE2DB24FA77C
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,979.20, is for the delivery of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,346.88, is for the delivery of BETAMETHASONE SP-AC 30 MG/5 ML 5ML, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the supply of Betamethasone SP-AC 30 mg/5 ml 5 ml. The contract has a total ceiling value of $3,120.00 and an ultimate completion date of November 28, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product, with a ceiling value of $40,708.85. The delivery order has a firm fixed price and is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Betamethasone SP-AC 30 mg/5 ml 5 ml medication. The contract has a firm fixed price of $1,174.93 and a period of performance through April 30, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4567316861 - BETAMETHASONE SP-AC 30 MG/5 ML 5ML. The contract has a ceiling value of $2,924.48 and a completion date of February 20, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $80,690 delivery order by the Defense Logistics Agency to provide 45 grams of betamethasone dipropionate 0.05% ointment. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price contract spanning July 5-6, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical supply vehicles to maintain medical product stockpiles for...
- On August 11, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 ml vials with a ceiling value of $27,745.17. This firm fixed-price delivery order, which must be completed by August 12, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Troop Support Medical awarded a $20,340 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for betamethasone sodium. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility on behalf of the Defense Logistics Agency under the agency's medical supplies contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages...
- The Defense Logistics Agency Troop Support Medical awarded a $33,540 delivery order to Amerisourcebergen Drug Corporation for betamethasone dipropionate 0.05% lotion in 60ml bottles. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by September 26, 2023 in support of DLA Troop Support Medical requirements. Amerisourcebergen will serve as the prime contractor to fulfill this delivery of pharmaceutical products under an indefinite delivery/indefinite...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA77CDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of BETAMETHASONE DP 0.05% OINT 15GM, a pharmaceutical product, to support the Department of Defense (DoD) and federal government. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,226.46 and a period of performance through January 11, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the DoD and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical and medical products to DLA facilities supporting the DoD worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/10/24 |